Massive study tracks safety of new psoriasis drug
NCT ID NCT03254667
Summary
This study is monitoring the long-term safety of the psoriasis medication brodalumab compared to other treatments. It will follow 3,500 adults with moderate-to-severe psoriasis who are already starting or switching to a systemic treatment as part of their regular care. The main goal is to track and compare the occurrence of serious side effects, like cancer, over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Registry
Bridgewater, New Jersey, 08807, United States
Conditions
Explore the condition pages connected to this study.